Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
Vlasic Labs CBD products have qualified for the CMS pilot program, signaling a key regulatory milestone. This CMS pilot program inclusion may influence insurance coverage and clinical practices. Clinicians should monitor this CMS pilot program as it…
Erectile CBD Gummies Review: A Practical Look at Claims, Evidence, and Everyday Use
This erectile CBD gummies review examines the claims and available evidence regarding their use for erectile dysfunction. While marketed for sexual health, clinical proof remains limited. Patients and clinicians should approach these products with…
CBD Reviews: Benefits, Efficacy, and Product Analysis for Informed Choices
CBD product evaluation challenges impact clinicians and patients alike. This article highlights the importance of clinical evidence and patient guidance. Understanding product quality and regulatory developments is essential for informed CBD use.
Do CBD Gummies Help with Smoking? What Users and Research Actually Show
CBD smoking cessation research is emerging as a potential aid for quitting tobacco. Current studies suggest CBD gummies may help reduce cigarette cravings and consumption. However, evidence remains limited and further research is needed.
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that…
Almost – CBD and THC Did More Than Just Affect Ovarian Cancer Cells in the Lab
Preclinical cancer research cannabinoids are generating significant interest, especially regarding CBD and THC effects on ovarian cancer cells. Laboratory studies show promising results but lack human clinical validation. Clinicians emphasize caution…
Cannabis and Sleep Review, Read Carefully
This paper is a systematic review and meta-analysis on recreational cannabis use and sleep in the general population. It brings together observational and experimental studies and finds that poorer sleep outcomes appear more often in observational data…
Study: Clinical evidence review for Cannabidiol
This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as…
Texas Hemp Ban Begins at Midnight: Houston Shop Owner Sounds the Alarm
The 2026 Texas hemp ban significantly affects patient access to hemp-derived products used for medical conditions. This regulatory change creates challenges for patients and clinicians navigating care continuity. Understanding the 2026 Texas hemp ban is…
Wyld CBD + CBN Gummies Review: Sleep Support Analysis
This Wyld CBD CBN gummies sleep support review examines consumer experiences and clinical perspectives on these cannabinoid combinations. While promising for relaxation, product safety and dosing remain critical considerations. Our review provides…